Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Leukemia

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    September 2022
  1. LIU ACH, Cathelin S, Yang Y, Dai DL, et al
    Targeting STAT5 signaling overcomes resistance to IDH inhibitors in acute myeloid leukemia through suppression of stemness.
    Cancer Res. 2022 Sep 23. pii: 709375. doi: 10.1158/0008-5472.CAN-22-1293.
    PubMed     Abstract available


    August 2022
  2. HNATIUK AP, Bruyneel AAN, Tailor D, Pandrala M, et al
    Reengineering Ponatinib to Minimize Cardiovascular Toxicity.
    Cancer Res. 2022;82:2777-2791.
    PubMed     Abstract available


    June 2022
  3. PFEIFFER A, Franciosa G, Locard-Paulet M, Piga I, et al
    Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD-Driven AML.
    Cancer Res. 2022;82:2141-2155.
    PubMed     Abstract available


    March 2022
  4. CASADO-GARCIA A, Isidro-Hernandez M, Oak N, Mayado A, et al
    Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice.
    Cancer Res. 2022;82:1098-1109.
    PubMed     Abstract available


  5. BRAUN T, Stachelscheid J, Bley N, Oberbeck S, et al
    Non-canonical function of AGO2 augments T-cell receptor signaling in T-cell prolymphocytic leukemia.
    Cancer Res. 2022 Mar 8. pii: 682091. doi: 10.1158/0008-5472.CAN-21-1908.
    PubMed     Abstract available


    December 2021
  6. PORAZZI P, Petruk S, Pagliaroli L, De Dominici M, et al
    Targeting chemotherapy to de-condensed H3K27me3-marked chromatin of AML cells enhances leukemia suppression.
    Cancer Res. 2021 Dec 13. pii: 0008-5472.CAN-21-1297.
    PubMed     Abstract available


    October 2021
  7. BIRAN A, Yin S, Kretzmer H, Ten Hacken E, et al
    Activation of Notch and Myc signaling via B cell-restricted depletion of Dnmt3a generates a consistent murine model of chronic lymphocytic leukemia.
    Cancer Res. 2021 Oct 22. pii: 0008-5472.CAN-21-1273.
    PubMed     Abstract available


  8. GOLDBERG L, Negi V, Chung YJ, Onozawa M, et al
    Mutant Idh2 Cooperates with a NUP98-HOXD13 Fusion to Induce Early Immature Thymocyte Precursor ALL.
    Cancer Res. 2021;81:5033-5046.
    PubMed     Abstract available


    September 2021
  9. SANJIV K, Calderon-Montano JM, Pham TM, Erkers T, et al
    MTH1 inhibitor TH1579 induces oxidative DNA damage and mitotic arrest in acute myeloid leukemia.
    Cancer Res. 2021 Sep 30. pii: 0008-5472.CAN-21-0061.
    PubMed     Abstract available


    July 2021
  10. MAIFREDE S, Le BV, Nieborowska-Skorska M, Golovine K, et al
    TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors.
    Cancer Res. 2021 Jul 2. pii: 0008-5472.CAN-20-3761.
    PubMed     Abstract available


    February 2021
  11. O'HAGAN HM, Rassool FV, Nephew KP
    How Epigenetic Therapy Beats Adverse Genetics in Monosomy Karyotype AML.
    Cancer Res. 2021;81:813-815.
    PubMed     Abstract available


  12. GREVE G, Schuler J, Gruning BA, Berberich B, et al
    Decitabine Induces Gene Derepression on Monosomic Chromosomes: In Vitro and In Vivo Effects in Adverse-Risk Cytogenetics AML.
    Cancer Res. 2021;81:834-846.
    PubMed     Abstract available


    January 2021
  13. DING H, Vincelette ND, McGehee CD, Kohorst MA, et al
    CDK2-mediated upregulation of TNFa as a mechanism of selective cytotoxicity in acute leukemia.
    Cancer Res. 2021 Jan 7. pii: 0008-5472.CAN-20-1504.
    PubMed     Abstract available


  14. TAMIRO F, Weng AP, Giambra V
    Targeting leukemia-initiating cells in acute lymphoblastic leukemia (ALL).
    Cancer Res. 2021 Jan 7. pii: 0008-5472.CAN-20-2571.
    PubMed     Abstract available


    December 2020
  15. ORAVECZ-WILSON K, Rossi C, Zajac C, Sun Y, et al
    ATG5-dependent autophagy uncouples T cell proliferative and effector functions and separates graft-versus-host disease from graft-versus-leukemia.
    Cancer Res. 2020 Dec 4. pii: 0008-5472.CAN-20-1346.
    PubMed     Abstract available


    October 2020
  16. SAINT FLEUR-LOMINY S, Evensen NA, Bhatla T, Sethia G, et al
    Evolution of the epigenetic landscape in childhood B acute lymphoblastic leukemia and its role in drug resistance.
    Cancer Res. 2020 Oct 16. pii: 0008-5472.CAN-20-1145.
    PubMed     Abstract available


    September 2020
  17. STIEHL T, Wang W, Lutz C, Marciniak-Czochra A, et al
    Mathematical Modeling Provides Evidence for Niche Competition in Human AML and Serves as a Tool to Improve Risk Stratification.
    Cancer Res. 2020;80:3983-3992.
    PubMed     Abstract available


  18. NGUYEN CH, Schlerka A, Grandits AM, Koller E, et al
    IL2RA promotes aggressiveness and stem cell-related properties of acute myeloid leukemia.
    Cancer Res. 2020 Sep 1. pii: 0008-5472.CAN-20-0531.
    PubMed     Abstract available


  19. TOHUMEKEN S, Baur R, Bottcher M, Stoll A, et al
    Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling.
    Cancer Res. 2020;80:3663-3676.
    PubMed     Abstract available


    August 2020
  20. KUIJJER ML
    Predicting Cancer Evolution Using Cell State Dynamics.
    Cancer Res. 2020;80:3072-3073.
    PubMed     Abstract available


    July 2020
  21. YANG F, Feng W, Wang H, Wang L, et al
    Monocyte-derived leukemia-associated macrophages facilitate extramedullary distribution of T-cell acute lymphoblastic leukemia cells.
    Cancer Res. 2020 Jul 10. pii: 0008-5472.CAN-20-0034.
    PubMed     Abstract available


    June 2020
  22. HAHNEL T, Baldow C, Guilhot J, Guilhot F, et al
    Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML.
    Cancer Res. 2020;80:2394-2406.
    PubMed     Abstract available


  23. SUN L, Li CW, Chung EM, Yang R, et al
    Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity.
    Cancer Res. 2020;80:2298-2310.
    PubMed     Abstract available


    May 2020
  24. ROCKNE RC, Branciamore S, Qi J, Frankhouser DE, et al
    State-transition analysis of time-sequential gene expression identifies critical points that predict development of acute myeloid leukemia.
    Cancer Res. 2020 May 15. pii: 0008-5472.CAN-20-0354.
    PubMed     Abstract available


    January 2020
  25. KLINGER M, Zugmaier G, Nagele V, Goebeler ME, et al
    Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse Events.
    Cancer Res. 2020;80:91-101.
    PubMed     Abstract available


    November 2019
  26. KONDO T, Ando M, Nagai N, Tomisato W, et al
    The NOTCH-FOXM1 Axis Plays a Key Role in Mitochondrial Biogenesis in the Induction of Human Stem Cell Memory-like CAR-T Cells.
    Cancer Res. 2019 Nov 25. pii: 0008-5472.CAN-19-1196.
    PubMed     Abstract available


    July 2019
  27. ROSS J, Rashkovan M, Fraszczak J, Joly Beauparlant C, et al
    Deletion of the Miz-1 POZ domain increases efficacy of cytarabine treatment in T- and B-ALL/lymphoma mouse models.
    Cancer Res. 2019 Jul 4. pii: 0008-5472.CAN-18-3038.
    PubMed     Abstract available


  28. DAS B, Pal B, Bhuyan R, Li H, et al
    MYC regulates the HIF-2alpha stemness pathway via Nanog and Sox2 to maintain self-renewal in cancer stem cells versus non-stem cancer cells.
    Cancer Res. 2019 Jul 2. pii: 0008-5472.CAN-18-2847.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: